New York State Common Retirement Fund’s Kindred Biosciences, Inc. KIN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-119,389
| Closed | -$1.09M | – | 3639 |
|
|
2021
Q2 | $1.09M | Sell |
119,389
-5,193
| -4% | -$30.2K | ﹤0.01% | 2188 |
|
|
2021
Q1 | $619K | Buy |
124,582
+26,900
| +28% | +$130K | ﹤0.01% | 2347 |
|
|
2020
Q4 | $421K | Hold |
97,682
| – | – | ﹤0.01% | 2432 |
|
|
2020
Q3 | $419K | Hold |
97,682
| – | – | ﹤0.01% | 2292 |
|
|
2020
Q2 | $439K | Hold |
97,682
| – | – | ﹤0.01% | 2287 |
|
|
2020
Q1 | $391K | Buy |
97,682
+19,350
| +25% | +$164K | ﹤0.01% | 2165 |
|
|
2019
Q4 | $664K | Hold |
78,332
| – | – | ﹤0.01% | 2148 |
|
|
2019
Q3 | $537K | Buy |
78,332
+6,890
| +10% | +$50.5K | ﹤0.01% | 2295 |
|
|
2019
Q2 | $595K | Sell |
71,442
-2,640
| -4% | -$22.8K | ﹤0.01% | 2283 |
|
|
2019
Q1 | $679K | Sell |
74,082
-5,550
| -7% | -$56.4K | ﹤0.01% | 2162 |
|
|
2018
Q4 | $872K | Sell |
79,632
-234,099
| -75% | -$2.95M | ﹤0.01% | 1983 |
|
|
2018
Q3 | $4.38M | Buy |
313,731
+32,132
| +11% | +$435K | 0.01% | 1325 |
|
|
2018
Q2 | $3M | Buy |
281,599
+38,350
| +16% | +$374K | ﹤0.01% | 1476 |
|
|
2018
Q1 | $2.1M | Buy |
243,249
+14,285
| +6% | +$125K | ﹤0.01% | 1596 |
|
|
2017
Q4 | $2.16M | Sell |
228,964
-36,579
| -14% | -$286K | ﹤0.01% | 1591 |
|
|
2017
Q3 | $2.08M | Buy |
265,543
+42,500
| +19% | +$319K | ﹤0.01% | 1602 |
|
|
2017
Q2 | $1.92M | Sell |
223,043
-57,801
| -21% | -$415K | ﹤0.01% | 1695 |
|
|
2017
Q1 | $1.98M | Sell |
280,844
-46,199
| -14% | -$289K | ﹤0.01% | 1682 |
|
|
2016
Q4 | $1.39M | Buy |
327,043
+6,842
| +2% | +$33.1K | ﹤0.01% | 1877 |
|
|
2016
Q3 | $1.59M | Hold |
320,201
| – | – | ﹤0.01% | 1774 |
|
|
2016
Q2 | $1.13M | Buy |
320,201
+21,500
| +7% | +$79K | ﹤0.01% | 1909 |
|
|
2016
Q1 | $1.03M | Buy |
298,701
+44,590
| +18% | +$157K | ﹤0.01% | 1925 |
|
|
2015
Q4 | $864K | Buy |
254,111
+84,000
| +49% | +$390K | ﹤0.01% | 2065 |
|
|
2015
Q3 | $885K | Buy |
170,111
+52,650
| +45% | +$325K | ﹤0.01% | 2014 |
|
|
2015
Q2 | $801K | Buy |
+117,461
| New | +$833K | ﹤0.01% | 2302 |
|
Other funds holding KIN
New York State Common Retirement Fund's KIN Position: Q3 2021 in Review
New York State Common Retirement Fund sold out of Kindred Biosciences, Inc. (KIN) in Q3 2021, closing a stake of 119,389 shares — an estimated $1.09M sold.
New York State Common Retirement Fund first reported a position in KIN in Q2 2015 and held it in 25 quarters. The position peaked at $4.38M in Q3 2018. 1 fund tracked by Wall St. Rank holds KIN as of Q3 2021.
- New York State Common Retirement Fund reported no remaining Kindred Biosciences, Inc. position as of Q3 2021 after selling out during the quarter.
- New York State Common Retirement Fund sold 119,389 Kindred Biosciences, Inc. shares in Q3 2021, an estimated $1.09M.
- New York State Common Retirement Fund first reported a position in Kindred Biosciences, Inc. in Q2 2015 and held it in 25 quarters.
- New York State Common Retirement Fund's Kindred Biosciences, Inc. position peaked at $4.38M in Q3 2018.
- 1 fund tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2021.
Based on New York State Common Retirement Fund's 13F filing for Q3 2021, filed 2 Nov 2021.